Top Home Health Trends For 2025

The year ahead will be a fascinating one in home health care. As 2025 dawns, the industry faces many uncertainties, and the next 12 months will be pivotal in shaping the future. Regulatory decisions will have an outsized impact on home health providers in the near-term, and their effects could stretch well into the future. […]

VitalCaring Deal Reportedly Suspended As UnitedHealth, Amedisys Seek Path Forward

Amedisys’ (Nasdaq: AMED) planned divestiture of more than 100 home health and hospice locations to VitalCaring has reportedly been halted following a federal court ruling that requires Texas-based VitalCaring to allocate a significant portion of its future profits to Encompass Health and Enhabit. Amedisys in June announced an agreement to sell some of its locations […]

Optum, LHC Group Put Pedal Down On Home-Based Care Efforts

LHC Group President and CEO Josh Proffitt on Wednesday shared a home-based, value-based vision for the company’s future. UnitedHealth Group’s (NYSE: UNH) Optum acquired LHC Group last year for $5.4 billion.  “Home Care remains deeply fragmented, disconnected and too difficult to navigate,” Proffitt said Wednesday. “It accounts for about $150 billion of the health sector […]

Evaluating The DOJ’s Arguments Against The UnitedHealth Group-Amedisys Deal

The U.S. Department of Justice (DOJ) and four state attorneys general filed a lawsuit to block UnitedHealth Group’s (NYSE: UNH) acquisition of Amedisys (Nasdaq: AMED) this week. The DOJ’s complaint is thorough, with some compelling arguments, and some less so. Home health veterans have been predicting consolidation of the fragmented industry for a long time. […]

DOJ Reportedly Prepping Lawsuit To Block UnitedHealth Group-Amedisys Deal

The Department of Justice is reportedly prepping a lawsuit to block UnitedHealth Group’s (NYSE: UNH) takeover of Amedisys (Nasdaq: AMED). Bloomberg first reported the news. Its report, citing anonymous sources, says that the Amedisys and UnitedHealth Group leaders did meet with DOJ officials last week. That meeting did not change the DOJ’s mind, however. UnitedHealth […]

DOJ Reportedly Delays Lawsuit Decision On UnitedHealth Group-Amedisys Deal

Amedisys (Nasdaq: AMED) and UnitedHealth Group (NYSE: UNH) leaders were reportedly set to meet with officials from the U.S. Department of Justice (DOJ) this week over their pending deal. The DOJ’s decision on whether to file a lawsuit to block the deal, however, has now reportedly been postponed until after the Nov. 5 presidential election. […]

UnitedHealth Group, Amedisys Set For All-Important Meeting With DOJ Officials

UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) leaders are reportedly expected to meet with officials from the Department of Justice over the next week to discuss their pending deal. The companies will likely make a final case for why the deal should go through, while the DOJ considers whether to officially file a lawsuit […]

Facing Headwinds, UnitedHealth Group Remains Focused On Value-Based Care

The Centers for Medicare & Medicaid Services’ (CMS) Medicare rate cuts, state-driven Medicaid member redeterminations and the Change Healthcare cyberattack. These are just three disruptions that UnitedHealth Group’s (NYSE: UNH) leadership has had to factor in when setting future growth objectives. “It’s a distinctive part of the culture of UnitedHealth Group that we continue to […]